title: Interferons should be used to treat most patients with MS.
authors.affiliation: Department of Neurology, G.V. (Sonny) Montgomery, Veterans Affairs Medical Center, University of Mississippi Medical School, Jackson 39216-5199, USA.
authors.forename: R M
authors.initials: RM
authors.lastname: Herndon
authors.forename: L
authors.initials: L
authors.lastname: Jacobs
mesh_terms: D003362:Cost-Benefit Analysis; D006233:Persons with Disabilities; D018450:Disease Progression; D006801:Humans; D007372:Interferons / Q000191:economics / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000191:economics / Q000473:pathology / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D007372:Interferons